The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Lilly; Merck; Pfizer; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Merck; Roche
Atezolizumab in first-line treatment of metastatic nonsquamous non-small cell lung cancer in the real-world setting.
 
Javier De Castro
No Relationships to Disclose
 
Begoña Campos Balea
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck; Roche; Sanofi
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Pfizer; Roche
 
Diego Perez Parente
Employment - Roche
 
Letizia Polito
Employment - Roche
 
Marcus Lawrance
Employment - Roche/Genentech
Stock and Other Ownership Interests - GlaxoSmithKline; Roche/Genentech
 
Pedro Ruiz Gracia
Employment - Roche
 
Leah Adler
Employment - Roche
 
Marta Marina Arroyo
Employment - Roche
 
Mark A. Socinski
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Guardant Health; Lilly; Merck; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech; Janssen; Lilly; Novartis
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Genentech (Inst); Spectrum Pharmaceuticals (Inst)